JT Stratford LLC’s ResMed RMD Stock Holding History

JT Stratford LLC’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$534K	Sell	2,740 -659	-19%	-$137K	0.06%	212
2026 Q1	$763K	Sell	3,399 -203	-6%	-$50.6K	0.1%	175
2025 Q4	$868K	Sell	3,602 -2,728	-43%	-$698K	0.11%	161
2025 Q3	$1.73M	Sell	6,330 -2,298	-27%	-$628K	0.23%	94
2025 Q2	$2.23M	Sell	8,628 -522	-6%	-$125K	0.34%	62
2025 Q1	$2.05M	Sell	9,150 -1,297	-12%	-$303K	0.36%	57
2024 Q4	$2.39M	Buy	10,447 +4,491	+75%	+$1.08M	0.39%	50
2024 Q3	$1.45M	Buy	5,956 +7	+0.1%	+$1.56K	0.25%	96
2024 Q2	$1.14M	Buy	5,949 +824	+16%	+$167K	0.21%	119
2024 Q1	$1.01M	Buy	+5,125	New	+$939K	0.2%	133

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JT Stratford LLC's RMD Position: Q2 2026 in Review

JT Stratford LLC reduced its ResMed (RMD) stake by 19% in Q2 2026, selling an estimated $137K and leaving 2,740 shares worth $534K. The position accounts for 0.06% of the portfolio, ranked #212.

JT Stratford LLC first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.39M in Q4 2024. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

JT Stratford LLC held 2,740 shares of ResMed worth $534K as of Q2 2026.
JT Stratford LLC sold 659 ResMed shares in Q2 2026, an estimated $137K.
ResMed made up 0.06% of JT Stratford LLC's portfolio in Q2 2026, its #212 holding.
JT Stratford LLC first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
JT Stratford LLC's ResMed position peaked at $2.39M in Q4 2024.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on JT Stratford LLC's 13F filing for Q2 2026, filed 14 Aug 2026.